Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.

about

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.

Item

http://www.wikidata.org/entity/Q47556460

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Personalized Antidepressant Se ...... ity of Targeting Inflammation.

@en

Personalized Antidepressant Se ...... ity of Targeting Inflammation.

@nl

type

Item

label

Personalized Antidepressant Se ...... ity of Targeting Inflammation.

@en

Personalized Antidepressant Se ...... ity of Targeting Inflammation.

@nl

prefLabel

Personalized Antidepressant Se ...... ity of Targeting Inflammation.

@en

Personalized Antidepressant Se ...... ity of Targeting Inflammation.

@nl

P1476

Personalized Antidepressant Se ...... ity of Targeting Inflammation.

@en

P2093

Madhukar H Trivedi

http://www.w3.org/2001/XMLSchema#string

Manish K Jha

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

From inflammation to sickness and depression: when the immune system subjugates the brain

C-reactive protein: a critical update

Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials

Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery

Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction

The depression treatment cascade in primary care: a public health perspective.

Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies.

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

P31

scholarly article

review article

P356

10.3390/IJMS19010233

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29329256

http://www.w3.org/2001/XMLSchema#string

P932

5796181

http://www.w3.org/2001/XMLSchema#string